Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Coleman

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Radiation Research|October 1, 1982
Secondary neoplasms in patients treated for cancer: etiology and perspectiveC N Coleman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
Carcinoma of the prostate: praising Stanford's accomplishmentsC N Coleman
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Young Investigators Workshop--Radiation Research Program, Radiation Oncology Sciences Program, National Cancer Institute, NIH, August 1-2 2000C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR)--conference summaryC N Coleman
The British Journal of Cancer. Supplement|July 1, 1996
Conference summary: the ninth international conference on the Chemical Modifiers of Cancer TreatmentC N Coleman
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Chemical sensitizers and protectorsC N Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Secondary malignancy after treatment of Hodgkin's disease: an evolving pictureC N Coleman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 1998
Of what use is molecular biology to the practicing radiation oncologist?C N Coleman
Acta Oncologica (Stockholm, Sweden)|December 28, 1999
Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Hypoxic cell radiosensitizers: expectations and progress in drug developmentC N Coleman
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Radiation Research|October 1, 1982
Secondary neoplasms in patients treated for cancer: etiology and perspectiveC N Coleman
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
Carcinoma of the prostate: praising Stanford's accomplishmentsC N Coleman
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Young Investigators Workshop--Radiation Research Program, Radiation Oncology Sciences Program, National Cancer Institute, NIH, August 1-2 2000C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR)--conference summaryC N Coleman
The British Journal of Cancer. Supplement|July 1, 1996
Conference summary: the ninth international conference on the Chemical Modifiers of Cancer TreatmentC N Coleman
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Chemical sensitizers and protectorsC N Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Secondary malignancy after treatment of Hodgkin's disease: an evolving pictureC N Coleman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 1998
Of what use is molecular biology to the practicing radiation oncologist?C N Coleman
Acta Oncologica (Stockholm, Sweden)|December 28, 1999
Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2C N Coleman
International Journal of Radiation Oncology, Biology, Physics|February 1, 1985
Hypoxic cell radiosensitizers: expectations and progress in drug developmentC N Coleman
Pageof 17